A strong immunoreactivity for AQP3 and AQP5 is observed in the ductal cells of patients with pancreatic ductal adenocarcinomas that is associated to tumor aggressiveness and tumor differentiation, respectively (Direito et al., 2017). The gene discussed is AQP5; the disease is neoplasm.